RU2008110083A - Ингибиторы протеинкиназы на основе алкоксииндолинонов - Google Patents
Ингибиторы протеинкиназы на основе алкоксииндолинонов Download PDFInfo
- Publication number
- RU2008110083A RU2008110083A RU2008110083/04A RU2008110083A RU2008110083A RU 2008110083 A RU2008110083 A RU 2008110083A RU 2008110083/04 A RU2008110083/04 A RU 2008110083/04A RU 2008110083 A RU2008110083 A RU 2008110083A RU 2008110083 A RU2008110083 A RU 2008110083A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- tautomer
- salt
- prodrug
- represented
- Prior art date
Links
- 0 *N(CC1)C1C(O)=O Chemical compound *N(CC1)C1C(O)=O 0.000 description 3
- ZWCXQKMDYCVHJT-UHFFFAOYSA-N CCCNC1CCOCC1 Chemical compound CCCNC1CCOCC1 ZWCXQKMDYCVHJT-UHFFFAOYSA-N 0.000 description 1
- KXECLDXTZBKCPW-PDGQHHTCSA-N CCOC(CNC(c1c(C)[nH]c(/C=C(/c2cc(F)ccc2N2)\C2=O)c1C)=O)C(N1CCOCC1)=O Chemical compound CCOC(CNC(c1c(C)[nH]c(/C=C(/c2cc(F)ccc2N2)\C2=O)c1C)=O)C(N1CCOCC1)=O KXECLDXTZBKCPW-PDGQHHTCSA-N 0.000 description 1
- HCKNAJXCHMACDN-UHFFFAOYSA-N CN(CC1)CCC1C(O)=O Chemical compound CN(CC1)CCC1C(O)=O HCKNAJXCHMACDN-UHFFFAOYSA-N 0.000 description 1
- UZFKBMGMRNOCRR-QPEQYQDCSA-N Cc1c(/C=C(/c(cc(cc2)F)c2N2)\C2=O)[nH]c(C)c1C(NCC(C(O)=O)OC)=O Chemical compound Cc1c(/C=C(/c(cc(cc2)F)c2N2)\C2=O)[nH]c(C)c1C(NCC(C(O)=O)OC)=O UZFKBMGMRNOCRR-QPEQYQDCSA-N 0.000 description 1
- IJDCPFZVPOXIBO-QMDZLVRISA-N Cc1c(/C=C(/c(cc(cc2)F)c2N2)\C2=O)[nH]c(C)c1C(NCC[C@@H](C(N(C)C)=O)OC)=O Chemical compound Cc1c(/C=C(/c(cc(cc2)F)c2N2)\C2=O)[nH]c(C)c1C(NCC[C@@H](C(N(C)C)=O)OC)=O IJDCPFZVPOXIBO-QMDZLVRISA-N 0.000 description 1
- JUNOWSHJELIDQP-UHFFFAOYSA-N OC(C1NCCOC1)=O Chemical compound OC(C1NCCOC1)=O JUNOWSHJELIDQP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71947405P | 2005-09-22 | 2005-09-22 | |
| US60/719,474 | 2005-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008110083A true RU2008110083A (ru) | 2009-10-27 |
Family
ID=37900093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008110083/04A RU2008110083A (ru) | 2005-09-22 | 2006-09-21 | Ингибиторы протеинкиназы на основе алкоксииндолинонов |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20090305382A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1926725A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009508971A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080046701A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101282965A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006294600A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0616378A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2621809A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2008110083A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007038251A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090305382A1 (en) * | 2005-09-22 | 2009-12-10 | The Scripps Research Institute | Alkoxy indolinone based protein kinase inhibitors |
| CA2663147A1 (en) | 2006-09-11 | 2008-03-20 | Curis, Inc. | Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| AU2007294686B2 (en) * | 2006-09-15 | 2013-10-31 | Equinox Sciences, Llc | Kinase inhibitor compounds |
| WO2013158367A1 (en) | 2012-04-20 | 2013-10-24 | Annji Pharmaceutical Co., Ltd. | Cyclopropanecarboxylate esters of purine analogues |
| RS58384B1 (sr) | 2014-03-07 | 2019-04-30 | Hoffmann La Roche | Novi 6-fuzionisani heteroarildihidropirimidini za lečenje i profilaksu infekcije virusom hepatitisa b |
| KR20220020412A (ko) | 2015-03-16 | 2022-02-18 | 에프. 호프만-라 로슈 아게 | Tlr7 작용제 및 hbv 캡시드 조립 억제제를 사용하는 병용 치료 |
| MX388408B (es) | 2016-09-13 | 2025-03-19 | Hoffmann La Roche | Tratamiento combinado con un agonista de tlr7 y un inhibidor de montaje de capsida de hbv |
| CN110016052B (zh) * | 2018-01-08 | 2021-09-28 | 四川海思科制药有限公司 | N-去乙基舒尼替尼的磷酰胺衍生物及其制备方法 |
| WO2020193459A1 (en) | 2019-03-25 | 2020-10-01 | F. Hoffmann-La Roche Ag | Solid forms of a compound of hbv core protein allosteric modifier |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US72934A (en) * | 1867-12-31 | Improvement in marking-gauge fob sswim-mgohines | ||
| AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| TWI259081B (en) * | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| BRPI0416994A (pt) * | 2003-11-26 | 2007-02-06 | Scripps Research Inst | inibidores de proteìna cinase com base em indolinona avançada |
| US20090305382A1 (en) * | 2005-09-22 | 2009-12-10 | The Scripps Research Institute | Alkoxy indolinone based protein kinase inhibitors |
-
2006
- 2006-09-21 US US11/991,971 patent/US20090305382A1/en not_active Abandoned
- 2006-09-21 WO PCT/US2006/036946 patent/WO2007038251A1/en not_active Ceased
- 2006-09-21 RU RU2008110083/04A patent/RU2008110083A/ru not_active Application Discontinuation
- 2006-09-21 AU AU2006294600A patent/AU2006294600A1/en not_active Abandoned
- 2006-09-21 JP JP2008532411A patent/JP2009508971A/ja not_active Withdrawn
- 2006-09-21 EP EP06815164A patent/EP1926725A4/en not_active Withdrawn
- 2006-09-21 BR BRPI0616378-5A patent/BRPI0616378A2/pt not_active IP Right Cessation
- 2006-09-21 KR KR1020087008492A patent/KR20080046701A/ko not_active Withdrawn
- 2006-09-21 CA CA002621809A patent/CA2621809A1/en not_active Abandoned
- 2006-09-21 CN CNA2006800352235A patent/CN101282965A/zh active Pending
- 2006-09-21 US US11/525,291 patent/US7629339B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2621809A1 (en) | 2007-04-05 |
| JP2009508971A (ja) | 2009-03-05 |
| US20090305382A1 (en) | 2009-12-10 |
| BRPI0616378A2 (pt) | 2011-06-21 |
| CN101282965A (zh) | 2008-10-08 |
| KR20080046701A (ko) | 2008-05-27 |
| AU2006294600A1 (en) | 2007-04-05 |
| EP1926725A4 (en) | 2010-10-06 |
| US7629339B2 (en) | 2009-12-08 |
| EP1926725A1 (en) | 2008-06-04 |
| US20070072934A1 (en) | 2007-03-29 |
| WO2007038251A1 (en) | 2007-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2624795T3 (es) | Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica | |
| AR048523A1 (es) | Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos | |
| AR059184A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica | |
| MX2021009763A (es) | Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos. | |
| AR069804A1 (es) | Agonistas del receptor glucocorticoide c20- c21 sustituido | |
| AR060658A1 (es) | Derivados de diceto-piperazina y piperidina como agentes antivirales | |
| ECSP10010337A (es) | Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica | |
| RU2008110083A (ru) | Ингибиторы протеинкиназы на основе алкоксииндолинонов | |
| AR081626A1 (es) | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos | |
| RU2007103815A (ru) | Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7(pde 7) активность | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| EA201070874A1 (ru) | Производные индол-2-карбоксамидов и азаиндол-2-карбоксамидов, замещённых силанильной группой, их получение и применение в терапии | |
| RU2011103454A (ru) | Бициклические гетероциклы в качестве ингибиторов киназы мек | |
| EA201070871A1 (ru) | Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии | |
| ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
| NI200900037A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica. | |
| AR058554A1 (es) | Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5. | |
| CO6300861A2 (es) | Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos | |
| ES2653419T3 (es) | Pirazolopirimidinilamino-indazoles sustituidos | |
| CO6220970A2 (es) | Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos | |
| RU2013147400A (ru) | Способ получения производных кето-бензофурана | |
| EA201070839A1 (ru) | Новые производные ацилцианопирролидинов | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| PH12017501655B1 (en) | Morphinan derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110112 |